TEAS Plus New Application

PAXLOVID

Pfizer Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 04/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90642654
Filing Date: 04/13/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK PAXLOVID
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT PAXLOVID
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Pfizer Inc.
*MAILING ADDRESS 235 East 42nd Street
*CITY New York
*STATE
(Required for U.S. applicants)
New York
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
10017
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Richard A. Friedman
ATTORNEY DOCKET NUMBER T 433748
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Pfizer Inc.
STREET 235 East 42nd Street
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10017
EMAIL ADDRESS deadlinesipnyo@pfizer.com
OTHER APPOINTED ATTORNEY Tiffany Trunko, Heather A. McDonald, Janina Gorbach and Andrea Christensen
CORRESPONDENCE INFORMATION
NAME Richard A. Friedman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE deadlinesipnyo@pfizer.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /RAF/
* SIGNATORY'S NAME Richard A. Friedman
* SIGNATORY'S POSITION Assistant General Counsel - Trademarks & Attorney of Record
SIGNATORY'S PHONE NUMBER 212-733-0086
* DATE SIGNED 04/13/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 04/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90642654
Filing Date: 04/13/2021

To the Commissioner for Trademarks:

MARK: PAXLOVID (Standard Characters, see mark)
The literal element of the mark consists of PAXLOVID. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Pfizer Inc., a corporation of Delaware, having an address of
      235 East 42nd Street
      New York, New York 10017
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



The owner's/holder's proposed attorney information: Richard A. Friedman. Other appointed attorneys are Tiffany Trunko, Heather A. McDonald, Janina Gorbach and Andrea Christensen. Richard A. Friedman of Pfizer Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      235 East 42nd Street
      New York, New York 10017
      United States
      deadlinesipnyo@pfizer.com
The docket/reference number is T 433748.
Richard A. Friedman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Richard A. Friedman
       PRIMARY EMAIL FOR CORRESPONDENCE: deadlinesipnyo@pfizer.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /RAF/   Date: 04/13/2021
Signatory's Name: Richard A. Friedman
Signatory's Position: Assistant General Counsel - Trademarks & Attorney of Record
Signatory's Phone Number: 212-733-0086
Signature method: Sent to third party for signature
Payment Sale Number: 90642654
Payment Accounting Date: 04/13/2021

Serial Number: 90642654
Internet Transmission Date: Tue Apr 13 18:09:57 ET 2021
TEAS Stamp: USPTO/FTK-XXX.XXX.XX.XX-2021041318095723
7662-90642654-770c366a15ff9a2cc3f2653f19
471f24998fba187b1ca2e7c9bb01b17c2b9f8-DA
-09560982-20210413143927805840

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed